CCM
MDGL icon

Cutler Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Cutler Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,071
Closed -$126K – 98
2015
Q3 		$126K Hold
2,071
– – 0.06% 88
2015
Q2 		$161K Hold
2,071
– – 0.07% 77
2015
Q1 		$140K Buy
2,071
+285
+16% +$24.4K 0.06% 84
2014
Q4 		$165K Hold
1,786
– – 0.07% 71
2014
Q3 		$188K Hold
1,786
– – 0.08% 70
2014
Q2 		$255K Buy
1,786
+500
+39% +$73.1K 0.1% 79
2014
Q1 		$194K Sell
1,286
-714
-36% -$141K 0.08% 93
2013
Q4 		$367K Buy
+2,000
New +$366K 0.15% 81

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cutler Capital Management's MDGL Position: Q4 2015 in Review

Cutler Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2015, closing a stake of 2,071 shares — an estimated $126K sold.

Cutler Capital Management first reported a position in MDGL in Q4 2013 and held it in 8 quarters. The position peaked at $367K in Q4 2013. 75 funds tracked by Wall St. Rank hold MDGL as of Q4 2015.

  • Cutler Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Cutler Capital Management sold 2,071 Madrigal Pharmaceuticals shares in Q4 2015, an estimated $126K.
  • Cutler Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2013 and held it in 8 quarters.
  • Cutler Capital Management's Madrigal Pharmaceuticals position peaked at $367K in Q4 2013.
  • 75 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2015.

Based on Cutler Capital Management's 13F filing for Q4 2015, filed 2 Feb 2016.